Vulnerability   
Search   
    Search 324607 CVE descriptions
and 145615 test descriptions,
access 10,000+ cross references.
Tests   CVE   All  

Test ID:1.3.6.1.4.1.25623.1.0.804875
Category:Web application abuses
Title:Newtelligence dasBlog 'url' Parameter Open Redirect Vulnerability
Summary:Newtelligence dasBlog is prone to an open redirect vulnerability.
Description:Summary:
Newtelligence dasBlog is prone to an open redirect vulnerability.

Vulnerability Insight:
The error exists as the application does not
validate the 'url' parameter upon submission to the ct.ashx script.

Vulnerability Impact:
Successful exploitation will allow remote
attackers to create a specially crafted URL, that if clicked, would redirect
a victim from the intended legitimate web site to an arbitrary web site of the
attacker's choosing.

Affected Software/OS:
Newtelligence dasBlog versions
2.1 (2.1.8102.813), 2.2 (2.2.8279.16125), and 2.3 (2.3.9074.18820).

Solution:
No known solution was made available for at least one year since the disclosure of this vulnerability.
Likely none will be provided anymore.
General solution options are to upgrade to a newer release, disable respective features, remove the product or replace the product by another one.

CVSS Score:
5.8

CVSS Vector:
AV:N/AC:M/Au:N/C:P/I:P/A:N

Cross-Ref: Common Vulnerability Exposure (CVE) ID: CVE-2014-7292
BugTraq ID: 70654
http://www.securityfocus.com/bid/70654
http://seclists.org/fulldisclosure/2014/Oct/91
http://packetstormsecurity.com/files/128749/Newtelligence-dasBlog-2.3-Open-Redirect.html
http://www.tetraph.com/blog/cves/cve-2014-7292-newtelligence-dasblog-open-redirect-vulnerability
XForce ISS Database: dasblog-cve20147292-open-redirect(97667)
https://exchange.xforce.ibmcloud.com/vulnerabilities/97667
CopyrightCopyright (C) 2014 Greenbone AG

This is only one of 145615 vulnerability tests in our test suite. Find out more about running a complete security audit.

To run a free test of this vulnerability against your system, register below.




© 1998-2025 E-Soft Inc. All rights reserved.